KM Financial Solutions | FOCUS-Biotech-for-hire PeptiDream charts new path and becomes short target
55512
post-template-default,single,single-post,postid-55512,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

FOCUS-Biotech-for-hire PeptiDream charts new path and becomes short target

FOCUS-Biotech-for-hire PeptiDream charts new path and becomes short target

The promise of PeptiDream Inc’s
drug-discovery technology and its lucrative
research-for-hire contracts have made it a darling of the Tokyo
stock market. Now, those gains have made it a target for
short-seller Muddy Waters.

No Comments

Sorry, the comment form is closed at this time.